2-((S)-2-((S)-2-amino-4-phenylbutanamido)-4-methylpentanamido)-3-phenylpropanoate hydrochloride

Intermediate for Carfilzomib. Carfilzomib (trade name: Kyprolis) is an anti-cancer drug acting as a selective proteasome inhibitor. Carfilzomib has been approved by the U.S Food and Drug Administration on July 20, 2012.

Specifications

Product Name:                  2-((S)-2-((S)-2-amino-4-phenylbutanamido)-4-methylpentanamido)-3-phenylpropanoate hydrochloride

Synonyms:                         N/A

CAS Number:                     875309-82-3

Molecular Weight:            566.1387

Molecular Formula:          C32H40ClN3O4

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               O=C(N[C@H](C(N[C@@H](CC3=CC=CC=C3)C(OCC2=CC=CC=C2)=O)=O)CC(C)C)[C@@H](N)CCC1=CC=CC=C1.Cl

2-((S)-2-((S)-2-amino-4-phenylbutanamido)-4-methylpentanamido)-3-phenylpropanoate hydrochloride

  • $1,177.00
  • Ex Tax: $1,177.00

Available Options